IGFBP-3 inhibits cytokine-induced insulin resistance and early manifestations of atherosclerosis.
Metabolic syndrome is associated with visceral obesity, insulin resistance and an increased risk of cardiovascular diseases. Visceral fat tissue primarily consists of adipocytes that secrete cytokines leading to a state of systemic inflammation in obese conditions. One of the IGF-independent functio...
Main Authors: | Lathika Mohanraj, Ho-Seong Kim, Wei Li, Qing Cai, Ki Eun Kim, Hye-Jung Shin, Yong-Jae Lee, Woo Jung Lee, Jung Hyun Kim, Youngman Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3557269?pdf=render |
Similar Items
-
Insulin-like growth factor binding protein-3 induces senescence by inhibiting telomerase activity in MCF-7 breast cancer cells
by: Ahreum Kwon, et al.
Published: (2023-05-01) -
IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer
by: Qing Cai, et al.
Published: (2020-05-01) -
Hemidystonia as an Initial Manifestation of Leptomeningeal Metastasis
by: Hyun-Jung Jung, et al.
Published: (2009-10-01) -
Neuropsychiatric symptoms and seizure related with serum cytokine in epilepsy patients
by: Hye-Rim Shin, et al.
Published: (2022-05-01) -
Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer
by: Seung Tae Kim, et al.
Published: (2015-08-01)